Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores

John J. Connolly*, Eta S. Berner, Maureen Smith, Samuel Levy, Shannon Terek, Margaret Harr, Dean Karavite, Sabrina Suckiel, Ingrid A. Holm, Kevin Dufendach, Catrina Nelson, Atlas Khan, Rex L. Chisholm, Aimee Allworth, Wei Qi Wei, Harris T. Bland, Ellen Wright Clayton, Emily R. Soper, Jodell E. Linder, Nita A. LimdiAlexandra Miller, Scott Nigbur, Hana Bangash, Marwan Hamed, Alborz Sherafati, Anna C.F. Lewis, Emma Perez, Lori A. Orlando, Tejinder K. Rakhra-Burris, Mustafa Al-Dulaimi, Selma Cifric, Courtney Lynam Scherr, Julia Wynn, Hakon Hakonarson, Maya Sabatello*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Polygenic risk scores (PRS) have potential to improve health care by identifying individuals that have elevated risk for common complex conditions. Use of PRS in clinical practice, however, requires careful assessment of the needs and capabilities of patients, providers, and health care systems. The electronic Medical Records and Genomics (eMERGE) network is conducting a collaborative study which will return PRS to 25,000 pediatric and adult participants. All participants will receive a risk report, potentially classifying them as high risk (∼2-10% per condition) for 1 or more of 10 conditions based on PRS. The study population is enriched by participants from racial and ethnic minority populations, underserved populations, and populations who experience poorer medical outcomes. All 10 eMERGE clinical sites conducted focus groups, interviews, and/or surveys to understand educational needs among key stakeholders—participants, providers, and/or study staff. Together, these studies highlighted the need for tools that address the perceived benefit/value of PRS, types of education/support needed, accessibility, and PRS-related knowledge and understanding. Based on findings from these preliminary studies, the network harmonized training initiatives and formal/informal educational resources. This paper summarizes eMERGE's collective approach to assessing educational needs and developing educational approaches for primary stakeholders. It discusses challenges encountered and solutions provided.

Original languageEnglish (US)
Article number100906
JournalGenetics in Medicine
Volume25
Issue number9
DOIs
StatePublished - Sep 2023

Funding

This phase of the eMERGE network was initiated and funded by the NHGRI through the following grants: U01HG011172 (Cincinnati Children’s Hospital Medical Center), U01HG011175 (Children’s Hospital of Philadelphia), U01HG008680 ( Columbia University ), U01HG011166 ( Duke University ), U01HG011176 ( Icahn School of Medicine at Mount Sinai ), U01HG008685 ( Mass General Brigham), U01HG006379 ( Mayo Clinic ), U01HG011169 ( Northwestern University ), U01HG011167 ( University of Alabama at Birmingham ), U01HG008657 ( University of Washington ), U01HG011181 ( Vanderbilt University Medical Center ), and U01HG011166 ( Vanderbilt University Medical Center serving as the Coordinating Center).

Keywords

  • Education
  • Genome-Informed Risk Report
  • PRS
  • Polygenic risk score
  • eMERGE

ASJC Scopus subject areas

  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores'. Together they form a unique fingerprint.

Cite this